UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases

Journal of clinical oncology, 2002-09, Vol.20 (17), p.3644-3650

2002

Volltextzugriff (PDF)

Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2372-2377

2005

Volltextzugriff (PDF)

Adjuvant Concurrent Chemoradiation after Laser Surgery for Locally Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S448-S449

2007

Volltextzugriff (PDF)

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

International journal of radiation oncology, biology, physics, 2002-03, Vol.52 (3), p.739-747

2002

Volltextzugriff (PDF)

Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (4), p.915-922

2001

Volltextzugriff (PDF)

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non–small-cell lung cancer

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.402-408

2003

Volltextzugriff (PDF)

5568 POSTER Adjuvant concurrent chemoradiation after laser surgery for locally advanced head and neck cancer

European journal of cancer supplements, 2007, Vol.5 (4), p.343-344

2007

Volltextzugriff (PDF)

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial

International journal of radiation oncology, biology, physics, 2003-07, Vol.56 (4), p.1154-1160

2003

Volltextzugriff (PDF)

Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer

Seminars in radiation oncology, 2002, Vol.12 (1), p.50-58

Anlonadou, Dosia

2002

Volltextzugriff (PDF)

Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer

Seminars in oncology, 2003-12, Vol.30 (6), p.2-9

2003

Volltextzugriff (PDF)

Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S300-S300

2004

Volltextzugriff (PDF)

Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors

International journal of radiation oncology, biology, physics, 2004-09, Vol.60, p.S300-S300

2004

Volltextzugriff (PDF)

Darbepoetin alfa improves quality of life in cancer patients undergoing radiation, final results of a multicenter, open study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.18531-18531

2006

Volltextzugriff (PDF)

A Multicenter, Open Study Evaluating the Impact of Darbepoetin Alfa on Anaemia and Quality of Life, in Cancer Patients Undergoing Radiotherapy

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S82-S83

2005

Volltextzugriff (PDF)

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

International journal of radiation oncology, biology, physics, 2004-09, Vol.60, p.S162-S163

2004

Volltextzugriff (PDF)

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S162-S163

2004

Volltextzugriff (PDF)

Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group

International journal of radiation oncology, biology, physics, 2004-09, Vol.60, p.S140-S141

2004

Volltextzugriff (PDF)

Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.S140-S141

2004

Volltextzugriff (PDF)

Measurement of the restricted dose mean LET outside the primary beam of a 60Co radiotherapy unit

Radiation research, 1987-04, Vol.110 (1), p.142

1987

Volltextzugriff (PDF)

Measurement of the restricted linear energy transfer of stray radiation close to the treatment volume of 12 and 18 MeV clinical photon beams

Medical physics (Lancaster), 1989-03, Vol.16 (2), p.302-304

1989

Volltextzugriff (PDF)

Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study

European journal of cancer (1990), 2001-04, Vol.37, p.S144-S144

2001

Volltextzugriff (PDF)

Reduction of toxicities associated with radiochemotherapy in patients with locally advanced non-small cell lung cancer using amifostine

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.106-107

2002

Volltextzugriff (PDF)

32 Amifostine protects from acute toxicity patients with cancer of the cervix treated with radiochemotherapy

Radiotherapy and oncology, 2000-12, Vol.57, p.S31-S31

2000

Volltextzugriff (PDF)

Randomized phase III trial of radiation treatment plus or minus amifostine in patients with advanced-stage lung cancer

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (4), p.915-922

2001

Volltextzugriff (PDF)

Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.93-94

2002

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases

Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme

Adjuvant Concurrent Chemoradiation after Laser Surgery for Locally Advanced Head and Neck Cancer

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non–small-cell lung cancer

5568 POSTER Adjuvant concurrent chemoradiation after laser surgery for locally advanced head and neck cancer

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial

Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer

Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer

Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors

Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors

Darbepoetin alfa improves quality of life in cancer patients undergoing radiation, final results of a multicenter, open study

A Multicenter, Open Study Evaluating the Impact of Darbepoetin Alfa on Anaemia and Quality of Life, in Cancer Patients Undergoing Radiotherapy

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study

Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group

Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group

Measurement of the restricted dose mean LET outside the primary beam of a 60Co radiotherapy unit

Measurement of the restricted linear energy transfer of stray radiation close to the treatment volume of 12 and 18 MeV clinical photon beams

Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study

Reduction of toxicities associated with radiochemotherapy in patients with locally advanced non-small cell lung cancer using amifostine

32 Amifostine protects from acute toxicity patients with cancer of the cervix treated with radiochemotherapy

Randomized phase III trial of radiation treatment plus or minus amifostine in patients with advanced-stage lung cancer

Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study

Suchergebnisse filtern